Tag: coming
-
Cost-cutting deal with unions key to VW’s recovery
By Andreas Cremer BERLIN (Reuters) – Volkswagen's ability to agree a big cost-cutting plan with its powerful labor unions in the coming weeks could determine whether the German carmaker's shares make a full recovery from its emissions scandal. A year after it admitted using illegal software to rig diesel emissions tests, Volkswagen (VW) has still…
-
Novo plans larger study after encouraging semaglutide results
By Nikolaj Skydsgaard COPENHAGEN (Reuters) – Novo Nordisk's experimental injectable diabetes drug semaglutide reduced cardiovascular risk by 26 percent, according to results released on Friday, paving the way for a new and bigger study on the drug's benefits. Semaglutide is the third diabetes drug to show such heart benefits, after Novo's Victoza injectable and Eli…
-
U.S. drugmaker Biogen’s profit beats Street; CEO to leave
(Reuters) – Biogen Inc's quarterly adjusted profit blew past Wall Street estimates on higher sales of its multiple sclerosis drugs, and the company said Chief Executive George Scangos would leave in the coming months. Shares of the company, whose board also authorized a $5 billion share repurchase program, rose about 5 percent to $276 in…
-
Theranos hires executives to lead regulatory and compliance push
(Reuters) – Theranos Inc hired two executives to oversee regulatory, quality and compliance standards, in a bid to turn around the struggling blood-testing company after it received sanctions from U.S. regulators.
-
Roche beats forecasts on new drugs and one-off gain
By Ludwig Burger BASEL, Switzerland (Reuters) – Switzerland's Roche beat market expectations for adjusted net income in the first six months of the year, helped by cancer drug sales but also inflated by a one-off gain from its pensions scheme. Core earnings per share, adjusted for certain items, rose 7 percent to 7.74 Swiss francs…
-
Researchers developing effective chlamydia vaccine
Researchers at McMaster University, Canada, have presented the first promising steps towards a vaccine against chlamydia, a “silent” sexually transmitted infection (STI) that affects 113 million people worldwide each year and which can lead to infertility. The research, published in the journal Vaccine, could help protect people all over the world from chlamydia. If left…